Taimei Technology
Taimei Technology

Taimei Technology

DR36Ahrefs DR: 36/100. Below median. Measured by Ahrefs. Median 44.Agent27Agent Readiness: 27/100. Bottom 25%. Measured by StartupHub.ai. Median 41.

AI-powered digital platform for life sciences, accelerating clinical research and drug development.

Website
2013ActiveShanghai, China

About

Taimei Technology offers a digital intelligence platform for the life sciences industry, building digital infrastructure for a collaborative and innovative ecosystem. They provide digital and intelligent operations platforms for pharmaceutical R&D, pharmacovigilance, and marketing, serving pharmaceutical companies, CROs, and clinical trial institutions. Their solutions aim to accelerate drug approval, ensure patient safety, and make quality medicines accessible.

Key facts

At-a-glance profile data

Website
taimei.com
Headquarters
Shanghai, China
Founded
2013
Total funding
$209M (IPO)
Business model
B2B

Funding rounds

Funding rounds raised by Taimei Technology
DateRoundAmountPost-moneyLead investors
8 Oct 2024IPO$33M$283M-
27 Sept 2020Series E$176M$1.1BTencent, Hillhouse Capital

Tech stack

Detected on taimei.com, last scanned 2 Sept 2026. Run your own scan

Hosting
AWS
Email provider
Self-hosted
Add first review

Frequently asked

How much funding has Taimei Technology raised?

Taimei Technology has raised a total of $209M in funding. The most recent round on record is IPO.